Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist.
(2020) Fertility and sterility — Vol. 114, n° 4, p. 739-741 (2020)
Files
Details
- Authors
- Abstract
- (en) Uterine fibroids are the most frequent female pelvic tumors and the most frequent indication for hysterectomy, which is associated with morbidity rates of 5% to 8%. Undertaking a myomectomy is also not free of complication and alternative treatments, such as magnetic resonance–guided focused ultrasound and uterine embolization, are often proposed (1). However, there is still a need for medical therapy with the goal to postpone or avoid surgery in women wishing to do so and in women with fibroid-related infertility. [...]
- Affiliations
Citations
Donnez, J., & Dolmans, M.-M. (2020). Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist. Fertility and sterility, 114(4), 739-741. https://doi.org/10.1016/j.fertnstert.2020.07.028 (Original work published 2020)